FDA issued a Warning Letter to Fagron, Inc on 8/29/2018 for a later inspection.
483 Fagron Jan 2005

483 Fagron Jan 2005

Marie Fadden FDA$119.00 - Available Now

FDA investigators audited the Fagron - Saint Paul, MN, United States facility and issued inspectional observations (via FDA 483) on 21 Jan 2005.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jan 2005
  • Location: Saint Paul, United States
  • FEI: 1000174332
Add To Cart